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The pellicle of the protozoan parasite Toxoplasma gondii is a unique triple bilayer structure, consisting of the
plasma membrane and two tightly apposed membranes of the underlying inner membrane complex. Integral
membrane proteins of the pellicle are likely to play critical roles in host cell recognition, attachment, and
invasion, but few such proteins have been identified. This is in large part because the parasite surface is
dominated by a family of abundant and highly immunogenic glycosylphosphatidylinositol (GPI)-anchored
proteins, which has made the identification of non-GPI-linked proteins difficult. To identify such proteins, we
have developed a radiolabeling approach using the hydrophobic, photoactivatable compound 5-[125I]iodonaph-
thalene-1-azide (INA). INA can be activated by photosensitizing fluorochromes; by restricting these fluoro-
chromes to the pellicle, [125I]INA labeling will selectively target non-GPI-anchored membrane-embedded
proteins of the pellicle. We demonstrate here that three known membrane proteins of the pellicle can indeed
be labeled by photosensitization with INA. In addition, this approach has identified a novel 22-kDa protein,
named PhIL1 (photosensitized INA-labeled protein 1), with unexpected properties. While the INA labeling of
PhIL1 is consistent with an integral membrane protein, the protein has neither a transmembrane domain nor
predicted sites of lipid modification. PhIL1 is conserved in apicomplexan parasites and localizes to the parasite
periphery, concentrated at the apical end just basal to the conoid. Detergent extraction and immunolocaliza-
tion data suggest that PhIL1 associates with the parasite cytoskeleton.
Toxoplasma gondii is a ubiquitous protozoan pathogen ca-
pable of infecting warm-blooded mammals worldwide and an
opportunistic human pathogen in immunocompromised indi-
viduals and the fetus. Like other parasites of the phylum Api-
complexa, T. gondii is an obligate intracellular parasite; re-
peated cycles of invasion, replication, and lysis of host cells by
the tachyzoite stage are both a critical part of the parasite’s life
cycle and a cause of tissue damage during acute infection.
The shape and structural integrity of the tachyzoite are
maintained by several unique structural components. To-
gether, the plasma membrane and flattened vesicles of the
inner membrane complex (IMC) form the pellicle, a triple
bilayer characteristic of apicomplexan parasites. Underlying
the pellicle is a filamentous cytoskeletal structure known as the
subpellicular network. Two characterized proteins of this net-
work, IMC1 and IMC2, are homologous to the articulins of
ciliate protozoa and have structural similarity to mammalian
intermediate filament proteins (22). The subpellicular net-
work associates on its outer face with the IMC and on its
inner face with 22 subpellicular microtubules. The subpel-
licular microtubules, which extend in a spiral fashion two-
thirds the length of the parasite, are organized at the apical
end of the parasite by the basal polar ring, just posterior to
the tubulin-based conoid. The subpellicular network, the
subpellicular microtubules, and the pellicle are all excep-
tionally stable structures.
Integral membrane proteins of the pellicle are likely to func-
tion in signal transduction, interaction with extracellular sub-
strates (such as host cell ligands), force transduction for the
actin-myosin motor during invasion, and maintenance of inter-
actions among the pellicle, subpellicular network, and micro-
tubules. However, very few such proteins have been identified.
Parasite attachment is mediated in part by proteins secreted
onto the surface from the micronemes, specialized apical or-
ganelles involved in host cell invasion (reviewed in references
39 and 42). The characterization of a large family of glyco-
sylphosphatidylinositol (GPI)-anchored proteins known as the
SAGs (surface antigens) has suggested that a subset of these
proteins may also play a role in host cell adhesion (10, 13, 20,
21). Attempts to identify other non-GPI-anchored pellicle pro-
teins by conventional surface labeling methods have been se-
verely hindered by the abundance and immunodominance of
the SAG proteins (21).
In order to identify novel, non-GPI-anchored integral mem-
brane proteins of the parasite pellicle, we utilized the photo-
activatable compound 5-[125I]iodonaphthalene-1-azide (INA).
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INA is highly hydrophobic and partitions into the lipid bilayer
of cellular membranes (1, 2). Upon activation, the azide con-
verts to a reactive nitrene, which covalently binds to adjacent
protein domains within the lipid bilayer, tagging the mem-
brane-embedded portions with 125I (1, 2, 12). Activation of
INA can occur through two processes (36). Because INA par-
titions into all membranes of the parasite, direct activation,
which occurs when INA is exposed to UV light (314 nm),
identifies membrane-embedded proteins in multiple mem-
brane compartments. While direct activation of INA at wave-
lengths greater than 370 nm is negligible, INA can be indirectly
activated at these wavelengths through a process called pho-
tosensitization, which involves energy transfer from an excited
fluorochrome to any INA molecule within collisional distance
(26, 29, 30, 34–36). We therefore reasoned that, by confining
photosensitizing fluorochromes to the parasite pellicle, mem-
brane-embedded proteins of the pellicle could be selectively
labeled with INA.
We demonstrate here that this approach can indeed be
used to label a distinct subset of parasite proteins. Impor-
tantly, we show that INA is not incorporated efficiently into
the GPI-anchored proteins that dominate the parasite sur-
face and that known integral membrane proteins of the
pellicle are INA labeled. We identify a novel 22-kDa INA-
labeled protein, named PhIL1, which localizes to the para-
site periphery but is concentrated at the apical end. While
the function of PhIL1 is not known, it appears to associate
with the parasite cytoskeleton.
MATERIALS AND METHODS
Materials. All chemicals were from Sigma (St. Louis, MO) unless otherwise
noted. Protease inhibitor stocks contained 104 mM 4-(2-aminoethyl)benzenesul-
fonyl fluoride (AEBSF), 0.08 mM aprotinin, 2.1 mM leupeptin, 3.6 mM bestatin,
1.5 mM pepstatin A, and 1.4 mM E-64 in dimethyl sulfoxide (DMSO). All
materials used for two-dimensional (2-D) gel electrophoresis were of ultrapure
quality.
Parasite culture. The T. gondii RH(EP) wild-type strain was used in all ex-
periments except where noted. P(LK) and P(LK) B mutant (18) strains were
generously provided by L. Kasper. B/SAG1-TM parasites expressing a SAG1
chimera, in which the GPI anchor of SAG1 is replaced with the transmembrane
domain of human CD46 (38), were generously provided by J. Boothroyd. All
parasites were maintained by serial passage in confluent cultures of human
foreskin fibroblasts (HFFs) as previously described (37). Parasites released from
freshly lysed HFFs were filtered through 3-m Nuclepore syringe filters (What-
man, Clifton, NJ) to remove host cell debris and washed twice by centrifugation
(5 min, 1,000  g) in cold phosphate-buffered saline (PBS) before use.
C16-eosin labeling. Parasites were resuspended at 2  107 parasites/ml in PBS.
5-(N-Hexadecanoyl)aminoeosin (C16-eosin; Molecular Probes, Eugene, OR) was
added to 2 g/ml from a 2-mg/ml DMSO stock, and the suspension was rotated
for 15 min at 4°C in the dark. After addition of a 1/10 volume of fetal bovine
serum, parasites were pelleted, washed once in deoxygenating buffer (0.1 mg/ml
glucose oxidase, 0.1 mg/ml catalase, 25 mM glucose in PBS [23]), and incubated
in deoxygenating buffer for 20 min on ice in the dark. Parasites were examined
by fluorescence microscopy to confirm peripheral labeling before further manip-
ulations. Internal labeling was also sometimes observed; parasite preparations in
which 15% of the parasites exhibited internal labeling were not used.
[125I]INA synthesis and parasite labeling. All manipulations with [125I]INA
and INA-labeled parasites were done under low-light conditions. [125I]INA was
synthesized as previously described (2) using 1-amino-5-azidonaphthalene as the
starting material (Combinix Inc., San Mateo, CA). Briefly, 30 mg of the starting
compound was deazotized to the corresponding diazonium ion and solubilized in
1 ml 10% sulfuric acid. An aliquot of 250 l of the diazonium solution was mixed
with 10 l of a 10-mg/ml solution of sodium iodide (NaI) and 10 mCi of
radioactive [125I]NaI (Amersham, Piscataway, NJ). The mixture was incubated at
23°C for 1 h, followed by the addition of 20 l of a 100-mg/ml solution of NaI,
and incubated further for 20 min. The INA precipitate was extracted with 3 ml
hexane, passed through a silica gel minicolumn, and dried under a stream of
nitrogen. The dry INA was resolubilized in 200 l of DMSO. The yield was
typically 0.5 to 1.0 mCi of INA with a specific radioactivity of 1 Ci/mmol.
Reduced glutathione (15 mM final concentration) was added to 5  107
C16-eosin-labeled parasites, followed by approximately 25 Ci INA. Samples
were irradiated for 5 min on ice at a distance of 10 cm with either a 254-nm UV
lamp (UVP Inc., San Gabriel, CA) or a 115-V, 150-W lamp (Minebea Co.,
Tokyo, Japan) filtered by three 3-mm-thick Kopp CS 3-72 glass filters (F. J. Gray
and Co., Jamaica, NY). The cells were then pelleted at 14,000  g for 5 min at
4°C. Fluorescence microscopy confirmed that eosin labeling remained peripheral
after irradiation.
2-D gel electrophoresis. Samples were solubilized in one of two ways.
Octylglucoside method. Pellets (approximately 50 g parasite protein per
sample) were resuspended in 24 l lysis buffer (10 mM Tris, pH 7.4, 50 g/ml
RNase, 50 g/ml DNase, 1:100 [vol/vol] protease inhibitors) and subjected to
four freeze-thaw cycles in liquid nitrogen. Following addition of 16 l of sodium
dodecyl sulfate (SDS) buffer (0.3% [wt/vol] SDS, 200 mM dithiothreitol [DTT]),
the sample was sonicated in a water bath sonicator (Branson, Danbury, CT) for
20 min, heated at 50°C for 10 min, and then incubated at 23°C for 2 h. Octyl
buffer (160 l; 9.9 M urea, 4% [wt/vol] octylglucoside, 100 mM DTT, and 0.5%
[vol/vol] pH 3 to 10 or pH 4 to 7 ampholytes [Amersham]) was added, and the
sample was incubated for another hour at 23°C. Bromophenol blue was added to
0.01% (wt/vol), and insoluble material was removed by centrifugation for 30 min
(15,000  g) at 23°C.
ASB14 method. Parasite pellets (approximately 25 g of total parasite protein)
were resuspended in 200 l amidosulfobetaine-14 (ASB14) 2-D buffer consisting
of 7 M urea, 2 M thiourea, 2% (wt/vol) ASB14 (Calbiochem, San Diego, CA),
0.5% (vol/vol) Triton X-100 (TX-100; Pierce, Rockford, IL), 20 mM DTT, and
0.5% (vol/vol) ampholytes. After incubation at 23°C for 2 to 4 h, bromophenol
blue was added to 0.01% (wt/vol), and the sample was centrifuged as described
above.
Samples were added to 11-cm pH 4 to 7 immobilized pH gradient (IPG) strips
(Amersham) or pH 3 to 10 nonlinear (NL) IPG strips (Bio-Rad, Hercules, CA).
IPG strips were rehydrated with sample and focused for 35,000 V · hours
(Protean-IEF; Bio-Rad). For the second dimension, the strips were equilibrated
according to the manufacturer’s instructions prior to one-dimensional SDS-
polyacrylamide gel electrophoresis (PAGE) and silver staining as previously
described (6). Gels were dried and exposed to Bio-Max MS film (Eastman
Kodak, Rochester, NY).
Metabolic labeling and immunoprecipitation. Parasites were metabolically
labeled with [35S]methionine-cysteine for 20 to 24 h and extracted as previously
described (7), except that the TX-100 concentration was increased to 1% for
GAP45 immunoprecipitation. For GAP45 immunoprecipitation, supernatants
were incubated for 1 h at 4°C with 1:1,000 anti-GAP45 rabbit serum, followed by
incubation with protein A-Sepharose (Zymed, South San Francisco, CA) for 1 h
at 4°C. The beads were washed four times in TX-100 buffer, and bound proteins
were eluted in reducing SDS-PAGE sample buffer containing 4% (vol/vol)
-mercaptoethanol. For SAG1 immunoprecipitation, the supernatant was incu-
bated for 1 h at 4°C with 5 g/ml mouse anti-SAG1 monoclonal antibody (MAb;
Argene, North Massapequa, NY). Protein G-Sepharose (Amersham) was added
to the extract and incubated for 1 h at 4°C, followed by four washes with TX-100
buffer and elution in nonreducing SDS-PAGE sample buffer.
Immunoprecipitated proteins were resolved on 12% (wt/vol) acrylamide-SDS-
polyacrylamide gels, transferred to polyvinylidene difluoride membranes (Milli-
pore, Bedford, MA), and exposed to film. Following exposure, the membranes
were used for Western blotting as previously described (43) with either GAP45
antiserum (1:2,000) or anti-SAG1 antibody (0.25 g/ml) and detected by en-
hanced chemiluminescence (Amersham).
TX-114 phase partitioning. Parasites (1  109) were extracted in Triton X-114
(TX-114), phase partitioned, and digested with phosphatidylinositol-specific
phospholipase C (PI-PLC) as previously described (45). The detergent phase was
diluted in 10 mM Tris-HCl, pH 7.4, and the proteins were precipitated with 10
volumes of 100% acetone prechilled to 20°C. Insoluble material was pelleted
(15,000  g, 4°C), washed with 90% (20°C) acetone, and air dried at 23°C. The
dried pellet was resuspended in 24 l 10 mM Tris-HCl (pH 7.4), 1:100 (vol/vol)
protease inhibitors, and 16 l of SDS buffer; sonicated in a bath sonicator
(Branson) for 20 min; and incubated for 10 min at 100°C followed by 2 h at 23°C.
Octyl buffer (160 l) was added, and the sample was incubated for another 60
min at 23°C. The sample was then centrifuged (30 min, 15,000  g) and focused
on pH 3 to 10 NL IPG strips as described above.
Purification of PhIL1 and mass spectrometry analysis. Parasites were solubi-
lized with octylglucoside isofocusing buffer (approximately 300 g of total par-
asite protein) and focused on pH 4 to 7 IPG strips as described above. Following
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the second dimension, the gel was stained with SimplyBlue colloidal Coomassie
stain (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions.
The PhIL1 spot was excised, trypsinized, and subjected to microcapillary liquid
chromatography-tandem mass spectrometry (Taplin Biological Mass Spectrom-
etry Facility, Harvard, MA).
To determine the site(s) of INA modification, spots were excised from both
unlabeled and INA-labeled 2-D gels and analyzed by matrix-assisted laser
desorption–ionization mass spectrometry (Yale Cancer Center Mass Spectrom-
etry Resource, New Haven, CT).
Protein analysis was performed using MacVector v. 6.5.3 (Accelrys, San Diego,
CA) and PredictProtein (http://cubic.bioc.columbia.edu/predictprotein). Predic-
tion of amphipathic helices was done using HelixWheel (http://www.site.uottawa
.ca/turcotte/resources/HelixWheel), and prediction of -strand transmembrane
domains was done using MINNOU (http://minnou.cchmc.org).
Cloning of PhIL1. Total tachyzoite RNA was extracted using TRI reagent
(Sigma) according to the manufacturer’s instructions. The SuperScript first-
strand synthesis system (Invitrogen) was used to generate oligo(dT)-primed
first-strand cDNA from 2 g RNA. A 1.1-kb expressed sequence tag (EST)
sequence containing the PhIL1 open reading frame (ORF) was amplified, cloned
into TOPO-TA pCRII (Invitrogen), and sequenced. DNA sequence alignments
and analysis were performed using Sequencher v.3.1.1 (Gene Codes Corpora-
tion, Ann Arbor, MI), and ClustalW protein sequence alignments were per-
formed using MacVector.
To N-terminally tag PhIL1 with myc, the PhIL1 ORF was amplified with
PhIL1NcoIfor and PhIL1AvrIIrev and cloned in frame into the NcoI and AvrII
sites of pTet4myc (24), creating pTet4myc-PhIL1. myc-PhIL1 was then amplified
with BglIImycfor and PhIL1stopAvrIIrev and ligated into the BglII and AvrII
sites of pCNA-GFP (33). C-terminally green fluorescent protein (GFP)-tagged
PhIL1 was generated by amplifying the PhIL1 ORF using PhIL1BglIIfor and
PhIL1AvrIIrev and ligated in frame into the BglII and AvrII sites of PCNA-
GFP upstream of GFP. C-terminally yellow fluorescent protein (YFP)-tagged
PhIL1 was generated by cloning into the BglII and AvrII sites of
TUBIMC1YFP/sagCAT (16). PhIL11–81 was cloned into TUBIMC1YFP/
sagCAT to generate Nterm-YFP, and YFP-PhIL182–165 was cloned down-
stream of YFP in TUBIMC1YFP/sagCAT to generate YFP-Cterm.
PhIL1–glutathione S-transferase (GST) was generated by cloning in frame
into the BamHI and NotI sites of pGEX (Invitrogen).
PhIL1 polyclonal rabbit antibody. BL21 cells expressing PhIL1-GST were
induced with 1 mM IPTG (isopropyl--D-thiogalactopyranoside) for 1 h at 37°C.
Inclusion bodies were purified by first lysing bacterial pellets in B-PER protein
extraction reagent (Pierce), followed by centrifugation at 15,000  g for 15 min
at 4°C. The insoluble pellet was washed sequentially with (i) 50 mM Tris (pH
8.0)-1 mM EDTA containing 200 g/ml lysozyme, (ii) 50 mM Tris (pH 8.0)–1%
(vol/vol) TX-100, and twice with (iii) 50 mM Tris (pH 8.0)-500 mM guanidinium.
The final pellet was dissolved in 8 M urea and 5 mM DTT by being shaken for
1 hour (23°C), followed by centrifugation (15,000  g, 15 min, 4°C). PhIL1-GST
was refolded by adding the supernatant dropwise to refolding buffer (50 mM
Tris, pH 8.0, 1 mM EDTA, 1 M L-arginine, 1 mM reduced glutathione, 0.8 mM
oxidized glutathione) and stirring the mixture overnight at 4°C. The solution was
dialyzed against 50 mM Tris (pH 8.0), insoluble material was pelleted, and the
supernatant was incubated with glutathione-Sepharose for 1 hour at 4°C. The
beads were washed twice with 50 mM Tris, pH 8.0; PhIL1-GST was eluted with
15 mM reduced glutathione in 50 mM Tris, pH 8.0, and used as an antigen to
generate rabbit polyclonal serum (Cocalico, Reamstown, PA) as previously de-
scribed (9).
Polyclonal rabbit serum was purified using protein A-Sepharose as previously
described (7) and used at 4 g/ml for immunofluorescence assay and 400 ng/ml
for Western blotting.
Immunofluorescence. For deoxycholate (DOC) extraction, parasites were first
allowed to adhere to untreated coverslips for 30 min at 23°C in a humidified
chamber; after extraction (10 min, 23°C) in PBS containing 10 mM DOC and 0.5
mM MgCl2, the parasites were fixed in 4% formaldehyde for 10 min at room
temperature.
For the alpha-toxin experiments, parasites were treated with 20 nM Clostrid-
ium septicum alpha-toxin (generously provided by R. Tweten, University of
Oklahoma) for 4 hours and processed as previously described (45), except that
fixed and permeabilized parasites were incubated first with primary antibody
diluted at 1:2,000, followed by incubation with a 1:400 dilution of Alexa Fluor-
conjugated secondary antibody (Molecular Probes).
Approximately 24 h prior to use, parasites were added to confluent HFF
monolayers on glass coverslips. Extracellular parasites were allowed to adhere to
coverslips coated with Cell Tak (Becton Dickinson, Franklin Lakes, NJ) for 30 to
40 min on ice as described previously (43). Following fixation (2.5% [vol/vol]
formaldehyde-0.02% [vol/vol] glutaraldehyde for 20 min on ice or 100% meth-
anol for 10 min on ice), parasites were blocked and permeabilized in 1% (wt/vol)
bovine serum albumin (BSA)–0.25% (vol/vol) TX-100 in PBS for 10 to 20 min on
ice, followed by incubation with primary and secondary antibodies as previously
described (6). Primary antibodies used were MAb 45-15 (anti-IMC1) (45), MAb
88-70 (anti-ROP4) (7), and MAb 9E10 (anti-myc; developed by J. M. Bishop and
obtained from the Developmental Studies Hybridoma Bank, University of Iowa).
Differential detergent extraction. Parasites were extracted at 1  108/ml for 45
min on ice in one of the following buffers: TX-100 (1% [vol/vol] TX-100, 150 mM
NaCl, 50 mM Tris, pH 7.4, or 50 mM PIPES [piperazine-N,N-bis(2-ethanesul-
fonic acid)], pH 6.5), DOC (0.5% or 1% [vol/vol] DOC, 50 mM Tris, pH 7.4, 150
mM NaCl), radioimmunoprecipitation assay (RIPA) buffer (1% [vol/vol] TX-
100, 0.5% [vol/vol] DOC, 0.1% [vol/vol] SDS, 50 mM Tris, pH 8.0, 150 mM
NaCl), and TX-114 (10 mM Tris, pH 7.4, 150 mM NaCl, 0.5% [vol/vol] precon-
densed TX-114). Extraction in SDS buffer (1% [vol/vol] SDS, 50 mM Tris, pH
8.0, 150 mM NaCl) was done by boiling for 10 min. Extracts were then centri-
fuged (15,000  g) for 20 min. Equivalent amounts of supernatant and pellet
were run on 12% acrylamide-SDS gels, transferred to nitrocellulose, and ana-
lyzed by Western blotting with anti-PhIL1, MAb 45-15 (anti-IMC1), MAb B-5-
1-2 (antitubulin), and anti-GAP45.
Immunoelectron microscopy. Approximately 2  107 PhIL1-GFP parasites
were resuspended in 50 l PBS. Carbon-coated nickel grids (M400-Ni; EMS,
Hatfield, PA) were inverted on top of 10-l drops of parasites and incubated in
a humid chamber for 40 min. The grids were then transferred to 30-l drops of
extraction buffer (PBS with 0.5 mM MgCl2, 10 mM DOC), incubated for 10 min,
and rinsed three times with PBS. The grids were then fixed for 10 min with 3.7%
(vol/vol) formaldehyde in PBS and washed three times for 5 min each with PBS.
Free aldehyde groups were blocked by incubation with 50 mM glycine in PBS for
15 min followed by 15 min of incubation with 0.1% NaBH4 in PBS.
Grids were blocked with 5% (wt/vol) BSA in PBS for 40 min, washed three
times with incubation buffer (0.8% BSA, 10 mM NaN3), incubated overnight at
4°C with anti-PhIL1 antibody (or prebleed serum) diluted 1:1,000 in incubation
buffer, and washed six times for 5 min each in incubation buffer. The grids were
then inverted on 10-l drops of secondary antibody (anti-rabbit immunoglobulin
G conjugated with 1:160 1.4-nm gold [Nanoprobe Inc., Yaphank, NY] or 1:80
ultrasmall gold [EMS] diluted in incubation buffer), incubated for 8 h at 23°C and
12 h at 4°C, and washed six times for 1 min each and six times for 5 min each with
incubation buffer.
The grids were postfixed for 1.5 h with 1% (vol/vol) glutaraldehyde in PBS at
23°C, stored in distilled water at 4°C for 48 h, and washed in distilled water three
times for 1 min each and three times for 5 min each. Silver enhancement was
carried out using the HQ silver enhancement kit (Nanoprobes Inc.) by floating
grids on mixtures of the initiator, activator, and modulator for 3 min in a
light-tight chamber and then briefly washing the grids once with distilled water,
followed by 5-min and 10-min washes. Grids were negatively stained using 2%
phosphotungstic acid (pH 7.0) mixed with cytochrome c.
Nucleotide sequence accession number. The open reading frame of PhIL1 can
be accessed under GenBank accession number DQ186991.
RESULTS
Photosensitized labeling of parasite proteins. Selective pho-
tosensitized labeling with INA requires the restriction of the
photosensitizing fluorochrome to the membrane compartment
of interest, in our case the plasma membrane and tightly as-
sociated IMC membranes of the parasite pellicle. We estab-
lished conditions under which C16-eosin, which has previously
been shown to be an efficient photosensitizer (23), can be
concentrated in the parasite pellicle as determined by fluores-
cence microscopy (Fig. 1A).
We examined the pattern of proteins labeled by INA after
either direct activation or photosensitization with C16-eosin.
SDS-PAGE analysis showed that a large number of proteins
can be labeled through direct activation; these proteins are
predicted to be integral membrane proteins throughout the
cell (Fig. 1B). In the absence of C16-eosin, INA is not activated
at the higher wavelength of light used for photosensitization,
and consequently no proteins are labeled. However, in eosin-
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labeled parasites, a distinct subset of proteins is labeled
through photosensitization (Fig. 1B, arrows). Because the pho-
tosensitizing fluorochrome is concentrated in the parasite pel-
licle, these proteins are predicted to be integral membrane
proteins of the pellicle. While other fluorochromes such as
C18-fluorescein (5-octadecanoylaminofluorescein) and DiOC16
(3,3-dihexadecyloxacarbocyanine perchlorate) also showed
peripheral labeling (data not shown), C16-eosin was found to
be the most selective photosensitizer (i.e., it showed the largest
differences between proteins labeled by direct and photosen-
sitized activation) and was used for all subsequent experi-
ments.
Selective labeling of non-GPI-linked pellicle proteins. Be-
cause a goal of this work was to identify novel, non-GPI-linked
integral membrane proteins at the parasite periphery, it was
important to confirm that INA is not incorporated to a signif-
icant extent into the GPI-linked proteins that dominate the
parasite surface. We first examined the extent of INA incor-
poration into the most abundant GPI-anchored surface pro-
tein, SAG1 (18), in comparison to a recombinant SAG1-TM
chimera, in which the GPI anchor addition signal sequence of
SAG1 was replaced with the transmembrane domain and 33-
amino-acid cytoplasmic tail of human CD46. This SAG1-TM
chimera folds correctly and is targeted to the plasma mem-
brane (38). After photosensitized labeling with INA, SAG1
was immunoprecipitated from wild-type parasites [RH and
P(LK) strains], P(LK) parasites lacking SAG1 (B mutants),
and B mutants expressing the SAG1-TM chimera (B/SAG1-
TM). Both wild-type strains contain significant amounts of
SAG1 by Western blotting, but this SAG1 incorporates very
little INA (Fig. 2A, closed arrow). Transgenic parasites ex-
pressing the chimeric protein contain less SAG1-TM than the
amount of SAG1 in the wild-type strains, but this SAG1-TM is
heavily INA labeled (Fig. 2A, B/SAG1-TM; empty arrow). As
expected, no INA incorporation is detected in immunoprecipi-
tates from the SAG1-deficient B mutants. Thus, while very
little INA is incorporated into GPI-anchored SAG1, INA can
readily be incorporated into the same protein if it contains a
transmembrane domain, demonstrating that INA does not ef-
ficiently bind to the GPI anchor. In addition, the labeling of
SAG1-TM confirms the ability of C16-eosin at the parasite
surface to activate INA and to label a plasma membrane trans-
membrane protein by photosensitization.
We next examined the ability of INA to label other parasite
GPI-anchored proteins, which include more than 150 members
of the SAG family (17). Triton X-114 phase partitioning can be
used to enrich for membrane-associated proteins, including
GPI-anchored proteins, which partition into the detergent
phase (3). Digestion with PI-PLC cleaves the GPI anchor,
shifting GPI-anchored proteins from the detergent phase to
the aqueous phase (14, 45). To determine if INA labels GPI-
anchored proteins other than SAG1, we therefore compared
the 2-D INA labeling profile of proteins recovered in the
Triton X-114 detergent phase of control extracts (membrane-
associated proteins, including GPI-anchored proteins) to that
of those recovered in the detergent phase after PI-PLC treat-
FIG. 1. Photosensitized labeling of parasites with C16-eosin. (A) Fluorescence microscopy of T. gondii tachyzoites labeled with the photosen-
sitizing lipid analog C16-eosin demonstrates that the C16-eosin is highly concentrated in the parasite pellicle. Bar, 2.5 m. (B) Autoradiogram of
INA-labeled parasite proteins resolved by SDS-PAGE. In the absence of C16-eosin, INA can be activated directly only at wavelengths less than
360 nm. When parasites are labeled with C16-eosin, activation of INA at longer wavelengths results in a subset of proteins being labeled with INA
(arrows). D, direct activation; P, photosensitization. Controls for inadvertent direct or indirect activation of INA by ambient light showed that
high-intensity irradiation was necessary for significant INA incorporation (LT, samples left uncovered in ambient light; DK, samples wrapped in
foil). Numbers on the left indicate molecular mass in kDa.
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ment (which will deplete GPI-anchored proteins from the de-
tergent fraction). The profiles are virtually identical (data not
shown), indicating that the majority of INA-labeled proteins
are not GPI anchored.
While GPI-anchored proteins are located in the plasma
membrane, the multiprotein motor complex essential for par-
asite motility and invasion, consisting of myosin A (myoA),
myosin light chain, GAP45, and GAP50, is associated with the
IMC membrane (11). This membrane association is thought to
be mediated by GAP50, a transmembrane protein, and/or
GAP45, which is both myristoylated and palmitoylated. To test
whether any of the motor complex proteins could be labeled
with INA, we immunoprecipitated the complex from parasites
that had been INA labeled through either direct activation or
photosensitization. Neither myoA nor myosin light chain was
detectably labeled with INA (Fig. 2B and data not shown),
indicating that they are not membrane embedded. In contrast,
GAP45 showed faint INA labeling, and the fourth member of
the complex, GAP50, was heavily INA labeled through both
direct activation and photosensitization (Fig. 2B).
Collectively, these data demonstrate that photosensitiza-
tion can be used to label non-GPI-linked membrane pro-
teins of the pellicle, and they provide the first direct exper-
imental evidence that both GAP45 and GAP50 are indeed
membrane embedded.
Analysis of INA-labeled proteins by 2-D gel electrophoresis.
In order to isolate and characterize novel INA-labeled pro-
teins, extracts from labeled parasites were separated by 2-D gel
electrophoresis. A large number of parasite proteins can be
resolved on broad-pH-range gels (pH 3 to 10), as demon-
strated by silver staining (Fig. 3, left panel). A subset of these
proteins is labeled with INA through direct activation (Fig. 3,
middle panel). After photosensitized labeling (Fig. 3, right
panel), three groups of proteins can be identified: those that
are labeled by direct but not photosensitized labeling (filled
arrows), those that incorporate similar amounts of INA by
direct and photosensitized labeling (empty arrows), and those
that show increased INA labeling through photosensitization
(arrowhead). The first group corresponds to predicted integral
membrane proteins of intracellular compartments; the latter
two groups correspond to potential integral membrane pro-
teins of the parasite pellicle.
Identification of PhIL1. Our early attempts to resolve INA-
labeled proteins on 2-D gels utilized octylglucoside as the
major detergent; in these gels, two prominent photosensitized
proteins are seen in the pH 4 to 7 range. The first protein,
FIG. 2. INA preferentially labels non-GPI-linked integral membrane proteins of the pellicle. (A) (a) SAG1 was immunoprecipitated from
parasites labeled with INA through photosensitization and analyzed by SDS-PAGE/autoradiography. The parasite strains used were RH and
P(LK) (wild-type strains), a SAG1-deficient P(LK) strain (B mutant), and the SAG1-deficient strain expressing a transmembrane version of SAG1
(B/SAG1-TM). (b) Corresponding Western blot with anti-SAG1 antibody. GPI-anchored SAG1 shows weak labeling with INA (panel a, filled
arrow). In contrast, much smaller amounts of SAG1-TM [compare Western blotting signals of RH and P(LK) to that of B/SAG1-TM in panel b]
show significantly more INA incorporation (panel a, open arrow). The lanes shown were from the same blot and were exposed and adjusted for
contrast and brightness identically. (B) (a) Autoradiogram showing that immunoprecipitation of SDS-extracted 35S-labeled parasites with an
anti-GAP45 antibody yields primarily GAP45 (SDS), whereas the entire glideosome complex can be immunoprecipitated with the same antibody
under nondenaturing conditions (TX-100). The four major proteins in the immunoprecipitated complex are myoA, myosin light chain (MLC),
GAP45, and GAP50 (11). (b) Corresponding Western blot with anti-GAP45. (c) Autoradiogram of the INA-labeled proteins immunoprecipitated
with anti-GAP45 antibody shows that both GAP45 and GAP50 are labeled, through either direct or photosensitized INA activation, whereas
neither myosin light chain nor myoA is detectably labeled. Substoichiometric amounts of myoA were transferred to the nitrocellulose in this
particular experiment; other experiments in which the iodination profile of the immunoprecipitate was analyzed directly (i.e., without transfer for
Western blotting) confirmed the lack of detectable INA incorporation into myoA (data not shown). D, direct activation; P, photosensitization.
Numbers on the left indicate molecular mass in kDa.
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which resolves as a charge train containing four to five spots
(Fig. 4A, arrowhead), was identified as different isoforms of
GAP45 by Western blotting (data not shown). The second
protein (Fig. 4A, closed arrow) was purified on preparative
2-D gels, digested with trypsin, and analyzed by mass spectrom-
etry; the three identified tryptic peptides matched a single EST
found in the T. gondii EST database. The full-length ORF was
amplified by reverse transcription-PCR and sequenced, pre-
dicting a protein of 19 kDa, which we named PhIL1 (for photo-
sensitized INA-labeled protein 1; Fig. 4B). Southern blotting
indicated that the PhIL1 gene is a single-copy gene (data not
shown).
To confirm that the cloned sequence corresponds to the
protein labeled with INA, we generated transgenic parasites
expressing myc-tagged PhIL1. The myc-tagged PhIL1 localized
to the parasite periphery (data not shown), with a distribution
indistinguishable from that of the untagged protein (see be-
low). On 2-D gels of INA-labeled transgenic parasites, a new
spot with the predicted shift in molecular weight and pI, rela-
tive to untagged PhIL1, was both labeled with INA and rec-
ognized by anti-myc Western blotting (Fig. 4A, open arrow),
confirming the identity of PhIL1. Immunoprecipitation with an
antibody generated against recombinant PhIL1 also confirmed
that PhIL1 is labeled with INA through photosensitization
(data not shown).
PhIL1 does not contain any identifiable protein domains or
homologs in organisms outside the phylum Apicomplexa.
However, homologs are found in the EST and genomic data-
bases of other apicomplexan parasites (Fig. 4B). Although the
N-terminal portions of the predicted proteins are divergent,
the C-terminal portions share a high degree of sequence iden-
tity between species, suggesting a conserved function.
PhIL1 secondary structure and identification of INA-bind-
ing sites. While the labeling of PhIL1 with INA suggests that it
is an integral membrane protein, it does not contain a pre-
dicted transmembrane domain or a recognizable signal for
addition of lipid anchors. A growing number of integral mem-
brane proteins have been shown to horizontally insert them-
selves into one leaflet of the lipid bilayer via amphipathic
helices (27, 40). Secondary structure prediction of PhIL1 sug-
gests the presence of a potential amphipathic helix at the N
terminus (Fig. 4B, striped box). To gain a better understanding
of how PhIL1 could be membrane associated, we attempted to
identify the sites of INA addition by mass spectrometry. Of the
recovered peptides (approximately 40% coverage), one was
found to be labeled with a single INA molecule (Fig. 4B, solid
line). This peptide does not exhibit any obvious secondary
structural features (e.g., an amphipathic helix) that would pre-
dict membrane association, although it is highly conserved
among the different apicomplexan PhIL1 homologs.
PhIL1 localizes to the parasite periphery. In parasites ex-
pressing PhIL1 tagged with GFP, PhIL1-GFP localizes to the
parasite periphery (Fig. 5A). In addition, it is concentrated at
both ends of the parasite, but especially at the extreme apical
end, as seen by dual localization with the apical rhoptry protein
ROP4. A gap in PhIL1 staining is visible at the apical end of
the parasite (arrows, Fig. 5B; see also Fig. 6A and 8A), a
pattern reminiscent of the IMC and subpellicular network,
which are not contiguous around the parasite; however, this
gap is smaller than that typically seen for IMC1 staining (com-
pare PhIL1-GFP to 	-IMC1 in Fig. 5A; see also Fig. 8A).
When the parasites are oriented with their apical end towards
the viewer, it is clear that the gap in PhIL1 fluorescence cor-
responds to a tight ring at the extreme apical tip (see Fig. 8C).
A similar distribution of PhIL1-GFP is seen using methanol-
fixed parasites (data not shown).
To determine if PhIL1 is associated with the plasma mem-
brane or with the IMC, we examined the localization of PhIL1-
GFP in parasites treated with C. septicum alpha-toxin (11, 45).
Alpha-toxin binds to GPI-anchored proteins on the parasite
surface and inserts pores, resulting in the separation of the
plasma membrane from the IMC and the formation of large
plasma membrane blebs. In alpha-toxin-treated parasites,
PhIL1 is clearly not associated with these plasma membrane
blebs (Fig. 5B, bottom panels), indicating an association with
the IMC and/or the underlying cytoskeleton.
FIG. 3. 2-D gel electrophoresis of INA-labeled proteins. After either direct or photosensitized activation of INA, parasite proteins were
extracted in isoelectric focusing buffer containing ASB14 and resolved on pH 3 to 10 NL 2-D gels. Approximately 25 g of parasite protein was
loaded per gel. The INA-labeled proteins resolved under these conditions can be classified into three groups: those that are labeled by direct but
not photosensitized activation (filled arrows), those that show similar amounts of INA incorporation by both direct and photosensitized activation
(empty arrows), and those that show increased INA incorporation through photosensitization (arrowhead). Numbers on the left indicate molecular
mass in kDa.
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FIG. 4. Identification of PhIL1. (A) Proteins labeled with INA by either direct (top left panel) or photosensitized (top right panel) activation
were solubilized in octylglucoside isoelectric focusing sample buffer, resolved on pH 4 to 7 2-D gels, and visualized by autoradiography. One of
the major photosensitized proteins solubilized and resolved under these conditions, of approximately 22 kDa (arrow), was purified from
preparative 2-D gels and identified by mass spectrometry; this protein was named PhIL1. The other major labeled protein, which resolves as a
charge train (arrowhead), was identified as GAP45 by Western blotting (data not shown). The greater amount of GAP45 present on the 2-D gels
compared to that recovered in immunoprecipitates likely accounts for the greater GAP45 labeling intensity seen here, compared to Fig. 3. Numbers
on the left indicate molecular mass in kDa. Transgenic parasites expressing N-terminally myc-tagged PhIL1 were labeled with INA and analyzed
by 2-D gel electrophoresis, followed by autoradiography and anti-myc Western blotting. A new INA-labeled spot (empty arrow) appears in the
transgenic parasites with the predicted molecular weight and pI shift relative to untagged PhIL1; this spot is also recognized in the anti-myc
Western blot. Closed arrow, endogenous PhIL1; open arrow, myc-PhIL1. (B) Multiple sequence alignment of predicted PhIL1 proteins from
related apicomplexan parasites. Identical amino acid residues are boxed; similar residues are shaded gray. The peptide from T. gondii PhIL1
identified by mass spectrometry as INA labeled is indicated by a black line above the sequence. A predicted amphipathic helix in T. gondii is
indicated by the hatched box. Sequences are from Toxoplasma gondii GenBank accession number DQ186991; Eimeria tenella contig of GenBank
BM321695, CD659439, and CD346904; Neospora caninum CF273551; Plasmodium falciparum NP_703291; and Plasmodium berghei CAH97932.
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While PhIL1-GFP localizes to the periphery and is concen-
trated at the apical end, anti-PhIL1 immunofluorescence of
formaldehyde-fixed and TX-100-permeabilized parasites
results in only peripheral staining (Fig. 6A). However, when
parasites are extracted with DOC, which removes the plasma
membrane and IMC (22), the antibody now also strongly labels
the apical end (Fig. 6A), suggesting that, in the absence of
DOC extraction, the apical epitope is somehow masked. In
addition, spiraling stripes can sometimes be seen along the
length of DOC-extracted parasites (Fig. 6B). PhIL1 localiza-
tion by immunoelectron microscopy on DOC-extracted para-
sites confirms and extends the observations seen by immuno-
fluorescence assay: PhIL1 is found at the periphery of the
parasite but is concentrated at the apical end just basal to the
conoid (Fig. 6C). The conoid itself is not labeled.
PhIL1 is associated with the parasite cytoskeleton. The ob-
servation that PhIL1 remains associated with DOC-extracted
parasites suggests an interaction with the cytoskeleton under-
lying the IMC (22). To examine this further, we tested the
extractability of PhIL1 in a variety of detergents, pH condi-
tions, and salt concentrations. As can be seen in Fig. 8, deter-
gents typically used to extract membrane proteins (e.g., TX-
100, TX-114, and RIPA buffer) did not extract PhIL1, nor did
high salt (up to 500 mM; data not shown). PhIL1 is extracted
efficiently only when boiled in SDS; partial extraction occurs at
basic pH in combination with TX-100 (pH 11, 1% TX-100;
data not shown). This extraction profile is indistinguishable
from that of the T. gondii cytoskeletal proteins tubulin and
IMC1 and different from that of the membrane protein GAP45
(Fig. 7), suggesting that PhIL1 is associated with the parasite
cytoskeleton.
The conserved C terminus is necessary and sufficient for
proper targeting and cytoskeletal association of PhIL1. The
C-terminal half of PhIL1 is highly conserved (Fig. 4B). A
fusion between the PhIL1 C terminus and YFP (YFP-Cterm)
showed the same localization as full-length PhIL1, i.e., periph-
eral with concentration at the ends (Fig. 8A). In addition, both
full-length PhIL1-YFP and YFP-Cterm localize to daughter
parasites during parasite replication, a process in which two
daughter parasites are assembled inside the mother parasite
FIG. 5. Localization of PhIL1-GFP. (A) PhIL1-GFP localizes to the parasite periphery. It is also concentrated at both ends, but in particular
the apical end, as seen by dual fluorescence localization with the apical rhoptry protein ROP4. A gap can be seen in the PhIL1 staining at the
extreme anterior end (arrows; also Fig. 5B, 6A, and 8A); this gap is smaller than that seen for IMC1 (arrowheads). In parasites oriented towards
the reader, this gap is seen as a tight circle (Fig. 8C). Some faint nuclear staining is also occasionally observed (upper panels, PhIL1-GFP). Bars,
2.5 m. (B) C. septicum alpha-toxin causes separation of the plasma membrane from the IMC in extracellular parasites (45). The top panels show
the near-coincident distribution of SAG1 and PhIL1-GFP in untreated parasites. In toxin-treated parasites (bottom panels), PhIL1-GFP remains
with the IMC and/or the underlying cytoskeleton, whereas SAG1 is found in the plasma membrane blebs that separate from the IMC. Bar, 5 m.
DIC, differential interference contrast.
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FIG. 6. Localization of PhIL1 in DOC-extracted parasites. (A) In fixed, TX-100-permeabilized parasites expressing PhIL1-GFP ( DOC), both
anti-PhIL1 (middle panels) and anti-GFP (not shown) localize to the parasite periphery by immunofluorescence microscopy, but neither shows the apical
and posterior concentration seen by direct fluorescence microscopy of PhIL1-GFP (left panels). However, after extraction with deoxycholate ( DOC),
both antibodies label the apical and posterior ends. Bar, 5 m. (B) In DOC-extracted parasites, PhIL1 is also found in spiraling “stripes” along the body
of the parasite. Two independent examples of this labeling pattern are shown. Bar, 5 m. (C) DOC-extracted PhIL1-GFP parasites were incubated with
either preimmune sera or anti-PhIL1 antibody, followed by gold labeling and negative staining of the parasite “ghosts” with phosphotungstic acid. Very
little labeling is seen in the controls labeled with preimmune serum (data not shown). Using anti-PhIL1, labeling is observed along the body of the parasite
and in a concentrated “cape” (arrows) at the apical end, just basal to the conoid (arrowhead). No labeling of the conoid is seen. Labeling of the basal
end of the parasite is also observed, although this labeling is less pronounced than that at the apical end (data not shown). Bar, 1 m.
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(Fig. 8B and C). In contrast to the C-terminal portion of
PhIL1, the N-terminal portion fused to YFP does not localize
to the periphery, although localization to the apical ends of
both mother and daughter parasites is observed (data not
shown).
Like untagged PhIL1 (Fig. 7), PhIL1-YFP is not extracted in
TX-100 (data not shown). YFP-Cterm is also insoluble in TX-
100, while the N-terminal portion is soluble (data not shown).
These data indicate that the conserved C-terminal portion of
PhIL1 is sufficient for both cytoskeletal association and proper
apical and peripheral localization of the protein.
DISCUSSION
Few of the proteins that act at the T. gondii-host cell inter-
face are known, in particular integral membrane proteins of
the parasite pellicle that might function in motility, host cell
recognition, or signal transduction. To identify such proteins,
we have developed a method that utilizes the photoactivatable
aryl azide INA. INA partitions into the core of lipid bilayers
and can be activated via short-range energy transfer mecha-
nisms from photosensitizing fluorochromes. Photoactivated
INA is a highly reactive nucleophile that binds covalently to
lipids and proteins within the bilayer, inserting itself into sulf-
hydryls, amines, and phenol groups, with an apparent amino
acid preference for tryptophan and cysteine (5, 19, 35). If a
photosensitizing fluorochrome can be restricted to a specific
membrane compartment in the cell, it can be used to selec-
tively target INA labeling to the membrane-embedded pro-
teins in that compartment (36).
INA binds covalently to unsaturated carbons in the acyl
chains of membrane lipids, but it has not previously been
determined whether INA binds efficiently to lipid-anchored
membrane proteins. GPI-anchored proteins dominate the sur-
face of the parasite; SAG1 alone may constitute several per-
cent of total cell protein (18). Because our goal was to identify
novel, non-GPI-linked pellicle proteins, it was important to
establish that the GPI-anchored proteins would not be present
in our labeled protein profiles. The lipid moiety of the T. gondii
GPI anchor has been characterized as sn-1,2-diacylglyceride,
where sn-2 is palmitate and sn-1 either is shorter than palmi-
tate or contains a double bond(s), reducing its hydrophobicity
(41). Our data on the labeling of both SAG1 and GPI-an-
chored proteins as a whole indicate that INA incorporates very
inefficiently into T. gondii GPI-anchored proteins.
Both GAP50 and, to a lesser extent, GAP45 are labeled with
INA by photosensitization. The recent demonstration that
these two proteins are associated with the IMC, rather than the
plasma membrane (11), suggests that C16-eosin added extra-
cellularly to parasites partitions into the membrane(s) of the
IMC as well as the plasma membrane. The plasma membrane
and IMC are very tightly associated (45); C16-eosin may be
able to equilibrate across the narrow (
20-nm) aqueous gap
that separates the plasma membrane from the outermost
membrane of the IMC (8). Alternatively, the membranes may
be directly connected in some unknown way that allows the
C16-eosin added to the outside of the parasite access to the
membranes of the IMC. GAP50 contains a predicted trans-
membrane domain, but GAP45 does not; however, GAP45
appears to be both myristoylated and palmitoylated (unpub-
lished observations) and may insert itself into the membrane(s)
of the pellicle through these acyl chains. There are no data
available on INA labeling of myristate or palmitate anchors,
and it is possible that INA can incorporate, albeit inefficiently,
into one or both of these acyl chains. However, it is also
possible that another hydrophobic domain of GAP45 inserts
itself into the membrane and that INA binds to this portion of
the protein rather than the lipid anchor(s).
By SDS-PAGE, a subset of the parasite proteins labeled via
direct activation of INA was seen to be labeled through pho-
tosensitization. Analysis of photosensitized proteins on 2-D
gels led to the identification of PhIL1, a novel protein that is
highly conserved in apicomplexan parasites, including various
species of Plasmodium, the causative agents of malaria. When
Plasmodium falciparum extracts were probed by Western blot-
ting with the anti-TgPhIL1 antibody, a single protein of ap-
proximately 25 kDa was recognized, in agreement with the
predicted size (25.5 kDa) of the P. falciparum homolog (S. D.
Gilk and G. E. Ward, unpublished data). In addition, the
transcriptome data of DeRisi and colleagues indicate an in-
crease in P. falciparum PhIL1 expression during schizogeny,
the replicative stage of malaria parasites (4). These data are
consistent with our results showing that T. gondii PhIL1 local-
izes to the apical end of daughter parasites early in the process
of their assembly within the mother cell.
The fact that PhIL1 is labeled with INA suggests that it is an
integral membrane protein. However, PhIL1 does not have an
identifiable hydrophobic transmembrane domain(s), a pre-
dicted -strand transmembrane domain(s), or a predicted
site(s) of lipid modification, although the C-terminal domain
does contain two conserved cysteines that could potentially be
palmitoylated. While transmembrane and lipid-anchored pro-
teins are the most common types of integral membrane pro-
FIG. 7. The detergent extraction profile of PhIL1 suggests that it is
associated with the cytoskeleton. Parasites were extracted under a
variety of detergent and pH conditions, centrifuged at 15,000  g, and
analyzed by Western blotting using antibodies against PhIL1, IMC1,
tubulin, and GAP45. The extraction profiles of PhIL1, IMC1, and
tubulin are identical; each is efficiently extracted only when boiled in
SDS. RIPA, radioimmunoprecipitation assay buffer; p, pellet; s,
supernatant.
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FIG. 8. The conserved C terminus targets PhIL1 to the periphery and to the apex of developing daughter parasites during endodiogeny.
(A) The C-terminal portion of PhIL1 (YFP-Cterm) localizes to the parasite periphery and is concentrated at the apical end. The distributions of
PhIL1-YFP and YFP-Cterm (direct fluorescence) are shown, relative to IMC1 (indirect immunofluorescence). In contrast, an N-terminal YFP
fusion of PhIL1 does not target itself to the periphery of the parasite, although it is found at the apical end (data not shown). (B) During parasite
replication, where daughter parasites form within the mother, full-length PhIL1-YFP localizes to the apical ends of the forming daughters, anterior
to the gap in IMC1. YFP-Cterm is similarly targeted to daughter parasites. (C) When daughter parasites are oriented with their apical end towards
the reader, it is clear that the gap in PhIL1 apical fluorescence (here PhIL1-GFP) corresponds to a tight circle. All bars, 2.5 m.
1632 GILK ET AL. EUKARYOT. CELL
teins, others (“monotopic” proteins) insert themselves into the
membrane using amphipathic helices (27, 31, 40, 44). The
best-characterized of these proteins is prostaglandin synthase,
where two short amphipathic helices dimerize and insert them-
selves, parallel to the membrane plane, into one leaflet (27). In
T. gondii, two dense granule proteins, GRA2 and GRA3, are
secreted in a soluble form into the parasitophorous vacuole,
where they become tightly membrane bound (25, 28); both
contain predicted amphipathic helices, which are postulated to
insert themselves into the membranes of the tubulovesicular
network. PhIL1 contains one potential amphipathic helix at its
N terminus. It is unknown if this portion of the protein inserts
itself into the membrane; no N-terminal INA-labeled peptides
were recovered in our mass spectrometry analysis, but cover-
age of the predicted helix was incomplete.
GFP fusions demonstrated that the C-terminal half of the
protein is sufficient to confer proper localization of PhIL1. This
half of the protein contains no predicted amphipathic helices,
but a C-terminal INA-modified peptide was identified by mass
spectrometry. This peptide does not contain the potential sites
of palmitoylation mentioned above. PhIL1 is predicted to be a
globular protein, and INA has been known to bind to hydro-
phobic pockets of peripheral or even soluble proteins (36). It is
therefore possible that PhIL1 is not, in fact, membrane asso-
ciated but contains a hydrophobic pocket that is labeled with
INA. Alternatively, other proteins, such as influenza virus
hemagglutinin and glutathione S-transferase, do not contain
predicted transmembrane domains but have been shown to
reversibly insert themselves into membranes where they be-
come accessible to INA labeling (26, 29). Further studies are
needed to determine how PhIL1 is associated with the mem-
brane and if it is modified on additional sites with INA.
While the ability to label PhIL1 with INA suggests that the
protein is membrane associated, detergents commonly used to
extract membrane proteins do not solubilize PhIL1. High-salt
conditions used to strip peripheral proteins also do not remove
PhIL1; in fact, PhIL1 requires harsh ionic detergents such as
SDS for efficient solubilization. The extraction profile of PhIL1
is indistinguishable from that of two known T. gondii cytoskel-
etal proteins, tubulin and IMC1. Retrospective analysis of pro-
teomic data from partially purified conoid/apical complex
preparations (15) revealed that PhIL1 was strongly repre-
sented in the data set (15 partially overlapping peptides, for a
total of 109 out of the 165 amino acids [J. M. Murray and K.
Hu, unpublished data]). PhIL1 peptides were detected more
often in the “conoid-depleted” than the “conoid-enriched”
fraction, consistent with our immunolocalization data and the
hypothesis that PhIL1 is a cytoskeletal, nonconoid protein.
Intriguingly, when the pellicle membranes were removed
with DOC, PhIL1 sometimes appeared as spiraling “stripes”
down the body of the parasite. These PhIL1 stripes do not
colocalize with the subpellicular microtubules (Gilk and Ward,
unpublished). However, they are reminiscent of the longitudi-
nal “sutures” found at the junctions between the flattened
rectangular plates of the IMC (32), although no stripes of
PhIL1 staining were detected perpendicular to the longitudinal
stripes, i.e., corresponding to the sutures on the other edges of
the IMC plates. At both the apical and posterior ends, the
longitudinal sutures between the IMC plates converge in a
spiral; this could account for the increased amount of PhIL1
found at the ends of the parasites.
Little is known about the proteins that tie the tachyzoite
cytoskeleton (i.e., the subpellicular network and subpellicular
microtubules) to the tightly associated membranes of the pel-
licle. Our observation that PhIL1 has properties of both a
cytoskeletal protein and a membrane-embedded protein of the
IMC suggests that PhIL1 could play a role in mediating this
association. Further studies will be required to determine the
precise localization of PhIL1 relative to other structures at the
parasite periphery and to explore the possibility that PhIL1
plays a role in linking the pellicle membranes to the underlying
cytoskeleton.
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